Investing Profile

Carl Gordon

Photo of Carl  Gordon, Managing Partner at OrbiMed
cb
OrbiMed Managing Partner
$1M - $75.0M
$4.0M
63
$18B
CompanyStageDateRound SizeTotal Raised
Alterome Therapeutics
Series BApr 2024$130M
Series ANov 2022$35M
Series AJan 2022$64M
$230M
Co-investors: Thilo Schroeder (Nextech Invest), Arjun Goyal (Vida Ventures)
ENYO Pharma
Series CJan 2024$43M
Series BJun 2018$47M
$90M
Co-investors: Iain Dukes (OrbiMed), Raphael Wisniewski (Andera Partners)
BlossomHill Therapeutics
Series BJan 2024$100M
Series AMar 2021$71M
$170M
Star Therapeutics
Series CSep 2023$90M
$90M
Co-investors: Maha Katabi (Sofinnova Investments), Beth Seidenberg (Westlake Village BioPartners)
ADARx Pharmaceuticals
Series CAug 2023$200M
Series BJan 2023$46M
Series BSep 2021$75M
$320M
Co-investors: Simeon J. George (SR One), Lorence Kim (Third Rock Ventures)
Garuda Therapeutics
Series BFeb 2023$62M
Series ASep 2021$72M
$130M
Co-investors: Eric Aguiar (Aisling Capital), Shaan C. Gandhi (Northpond Ventures)
ArriVent Biopharma
Series BDec 2022$160M
$160M
Co-investors: Elena Viboch (General Catalyst), James Healy (Sofinnova Investments)
MBX Biosciences
Series BNov 2022$120M
Series AJul 2020$35M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Patrick Heron (Frazier Healthcare Partners)